![Ehab Elkhouly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Ehab Elkhouly worked as an Operations Director at Response Genetics, Inc. He then worked at Cancer Genetics, Inc. as a VP-Clinical Affairs & Site Operations from 2018 to 2019.
Dr. Elkhouly has an undergraduate degree from KasrAlAiny School of Medicine and a graduate degree from Paul Merage School of Business.
Former positions of Ehab Elkhouly
Companies | Position | End |
---|---|---|
CANCER GENETICS, INC. | Chief Tech/Sci/R&D Officer | 2019-05-31 |
RESPONSE GENETICS, INC | Chief Operating Officer | - |
Training of Ehab Elkhouly
KasrAlAiny School of Medicine | Undergraduate Degree |
Paul Merage School of Business | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
RESPONSE GENETICS, INC | Health Technology |
Private companies | 1 |
---|---|
Cancer Genetics, Inc.
![]() Cancer Genetics, Inc. Medical SpecialtiesHealth Technology Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. | Health Technology |
- Stock Market
- Insiders
- Ehab Elkhouly